PMC:7594251 / 77224-78092
Annnotations
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T544 | 18-19 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T545 | 143-144 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T546 | 166-167 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T547 | 196-197 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T548 | 364-365 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T549 | 579-580 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T550 | 612-619 | http://purl.obolibrary.org/obo/OBI_0100026 | denotes | organic |
| T551 | 612-619 | http://purl.obolibrary.org/obo/UBERON_0000468 | denotes | organic |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T53844 | 145-162 | Chemical | denotes | chemical compound | http://purl.obolibrary.org/obo/CHEBI_37577 |
| T67006 | 612-629 | Chemical | denotes | organic molecules | http://purl.obolibrary.org/obo/CHEBI_72695 |
| T41579 | 620-629 | Chemical | denotes | molecules | http://purl.obolibrary.org/obo/CHEBI_25367 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 768 | 205-209 | Gene | denotes | pill | Gene:8319132 |
| 769 | 463-478 | Disease | denotes | crystal defects | MESH:D000070657 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T509 | 0-78 | Sentence | denotes | ssNMR is becoming a more attractive alternative for several different reasons. |
| T510 | 79-224 | Sentence | denotes | One of them is the fact that it enables the characterization of a chemical compound in a solid-state form such as in a tablet/pill [356,357,358]. |
| T511 | 225-868 | Sentence | denotes | Moreover, ssNMR is not only restricted to analyzing the chemical structure but it can also provide insight into the physical properties of a compound such as polymorphism (different crystalline structures of the same compound), disorder (crystal defects and amorphous solids in the compound) or the presence of cocrystals (multicomponent crystal made of a compound and one or more small organic molecules) [356,357]. ssNMR can also be used to quantify the amount of crystalline against the amount of amorphous material in the sample to establish phase purity (the amount of desired phase separated from other, undesirable phase) [356,357,358]. |